Your browser doesn't support javascript.
loading
Results of the first German external quality assessment scheme for the detection of monkeypox virus DNA.
Vierbaum, Laura; Wojtalewicz, Nathalie; Kaufmann, Anne; Goseberg, Sabine; Kaiser, Patricia; Grunert, Hans-Peter; Dühring, Ulf; Zimmermann, Anika; Scholz, Annemarie; Michel, Janine; Nitsche, Andreas; Rabenau, Holger F; Obermeier, Martin; Schellenberg, Ingo; Zeichhardt, Heinz; Kammel, Martin.
Afiliação
  • Vierbaum L; INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories, Dusseldorf, Germany.
  • Wojtalewicz N; INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories, Dusseldorf, Germany.
  • Kaufmann A; INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories, Dusseldorf, Germany.
  • Goseberg S; INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories, Dusseldorf, Germany.
  • Kaiser P; INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories, Dusseldorf, Germany.
  • Grunert HP; GBD Gesellschaft für Biotechnologische Diagnostik mbH, Berlin, Germany.
  • Dühring U; GBD Gesellschaft für Biotechnologische Diagnostik mbH, Berlin, Germany.
  • Zimmermann A; IQVD GmbH, Institut für Qualitätssicherung in der Virusdiagnostik, Berlin, Germany.
  • Scholz A; IQVD GmbH, Institut für Qualitätssicherung in der Virusdiagnostik, Berlin, Germany.
  • Michel J; Robert Koch-Institute, Centre for Biological Threats and Special Pathogens, Highly Pathogenic Viruses, German Consultant Laboratory for Poxviruses, Berlin, Germany.
  • Nitsche A; Robert Koch-Institute, Centre for Biological Threats and Special Pathogens, Highly Pathogenic Viruses, German Consultant Laboratory for Poxviruses, Berlin, Germany.
  • Rabenau HF; Institute for Medical Virology, University Hospital, Goethe University Frankfurt, Frankfurt, Hesse, Germany.
  • Obermeier M; Medizinisches Infektiologiezentrum Berlin, Berlin, Germany.
  • Schellenberg I; INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories, Dusseldorf, Germany.
  • Zeichhardt H; Institute of Bioanalytical Sciences, Center of Life Sciences, Anhalt University of Applied Sciences, Bernburg, Saxony-Anhalt, Germany.
  • Kammel M; INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories, Dusseldorf, Germany.
PLoS One ; 18(4): e0285203, 2023.
Article em En | MEDLINE | ID: mdl-37115793
ABSTRACT

BACKGROUND:

In May 2022, the monkeypox virus (MPXV) spread into non-endemic countries and the global community was quick to test the lessons learned from the SARS-CoV-2 pandemic. Due to its symptomatic resemblance to other diseases, like the non-pox virus varicella zoster (chickenpox), polymerase chain reaction methods play an important role in correctly diagnosing the rash-causing pathogen. INSTAND quickly established a new external quality assessment (EQA) scheme for MPXV and orthopoxvirus (OPXV) DNA detection to assess the current performance quality of the laboratory tests.

METHODS:

We analyzed quantitative and qualitative data of the first German EQA for MPXV and OPXV DNA detection. The survey included one negative and three MPXV-positive samples with different MPX viral loads. The threshold cycle (Ct) or other measures defining the quantification cycle (Cq) were analyzed in an assay-specific manner. A Passing Bablok fit was used to investigate the performance at laboratory level.

RESULTS:

141 qualitative datasets were reported by 131 laboratories for MPXV detection and 68 qualitative datasets by 65 laboratories for OPXV detection. More than 96% of the results were correctly identified as negative and more than 97% correctly identified as positive. An analysis of the reported Ct/Cq values showed a large spread of these values of up to 12 Ct/Cq. Nevertheless, there is a good correlation of results for the different MPXV concentrations at laboratory level. Only a few quantitative results in copies/mL were reported (MPXV N = 5; OPXV N = 2), but the results correlated well with the concentration differences between the EQA samples, which were to a power of ten each.

CONCLUSION:

The EQA results show that laboratories performed well in detecting both MPXV and OPXV. However, Ct/Cq values should be interpreted with caution when conclusions are drawn about the viral load as long as metrological traceability is not granted.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Orthopoxvirus / Mpox / COVID-19 Tipo de estudo: Diagnostic_studies / Qualitative_research Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Orthopoxvirus / Mpox / COVID-19 Tipo de estudo: Diagnostic_studies / Qualitative_research Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article